Hearts & Minds Blog

Cardiovascular Disease Awareness: Heart Healthy Initiatives Underway at Esperion

Tricia Mullins

Executive Director, Advocacy & Professional Relations

I am very excited to join my Esperion colleagues, their families and pets to participate in the Washtenaw County American… more

ACC Scientific Session Reflections: A Conversation Among Members of The Lipid Management Team

Tim Mayleben

President and Chief Executive Officer

Mary McGowan

Chief Medical Officer

Marianne Andreach

Senior Vice President, Strategic Marketing and Product Planning

Last week The Lipid Management team attended the American College of Cardiology (ACC) 66th Annual Scientific Session in Washington D.C…. more

Validating Our Approach: Dr. Ference to Present Results from Mendelian Randomization Studies of ACL Inhibition at the Upcoming ACC Scientific Session

Tim Mayleben

President and Chief Executive Officer

As a team of lipid management experts, we often “geek out” on the science behind LDL-cholesterol lowering therapies. That’s why… more

Bempedoic Acid Mechanism of Action Paper Published in Nature Communications: Q&A with the Authors

Narendra Lalwani, PhD, MBA, FAHA

Executive Vice President, Research and Development, and Chief Operating Officer

Marianne Andreach

Senior Vice President, Strategic Marketing and Product Planning

Steve Pinkosky

Senior Scientist, Head of Translational Research

As you may have seen, Esperion scientists and collaborators recently published the definitive paper on the mechanism of action for… more

The History of LDL-Cholesterol with Dr. Antonio Gotto

Tim Mayleben

President and Chief Executive Officer

Antonio M. Gotto, Jr., MD, DPhil

Dean Emeritus and Co-Chair of Board of Overseers, Weill Cornell Medical College

As you know, Esperion is focused on developing and commercializing therapies for the treatment of patients with hypercholesterolemia who are… more